Respiratory inhalers are medical devices used for the treatment of respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD). Dry powder inhalers (DPI) and metered dose inhalers (MDI) are the most common types of respiratory inhalers. DPIs contain medication in powder form and require the patient to inhale forcefully. MDIs contain medication in pressurized liquid form and require coordination of actuation and inhalation. Inhalers help deliver medication directly to the respiratory tract for quicker symptomatic relief. They have minimal systemic effects and are generally well-tolerated. The global respiratory inhalers market is estimated to be valued at US$ 29.55 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics: The rising prevalence of respiratory diseases like asthma and COPD is expected to drive the growth of the respiratory inhalers market. According to WHO, asthma currently affects an estimated 262 million people worldwide. It is a common long-term condition that can cause wheezing, breathlessness, chest tightness and coughing. Inhalers provide quick relief during asthma attacks and are thus widely used. Similarly, COPD prevalence is increasing due to rising pollution levels and cigarette smoking. It was responsible for over 3 million deaths globally in 2019 according to WHO. Inhalers such as bronchodilators are mainly used for symptom relief in COPD. Newer smart inhalers with sensors are also gaining traction as they can track medication use and provide feedback to patients and doctors. These factors coupled with growing awareness about respiratory diseases are expected to boost the respiratory inhalers market during the forecast period. SWOT Analysis Strength: Respiratory inhalers offer quick relief from asthma and COPD symptoms. They are portable and provide relief instantly in emergency situations. Moreover, advanced digital inhalers provide real-time monitoring and feedback which help patients manage their conditions better. Weakness: Reliance on frequent refills can be costly for patients over the long run. Some patients also find it difficult to use inhalers properly. Certain inhalers also require regular maintenance like cleaning. Opportunity: Growing awareness about respiratory diseases and their management presents an opportunity for inhaler manufacturers. Increasing healthcare expenditure in developing nations also expands the customer base. Moreover, development of combinational inhalers targeting multiple conditions can boost the market. Threats: Alternative delivery methods like oral medications and nebulizers provide competition. Stringent regulations on new product approval delays market entry. Supply chain and production disruptions from events like COVID-19 pandemic can also adversely impact the industry. Key Takeaways The global Respiratory Inhalers Market Share is expected to witness high growth over the forecast period. Rising cases of asthma and COPD due to environmental pollution and changing lifestyle habits is driving the need for effective therapeutic solutions. North America currently dominates the market due to high healthcare expenditures and advanced healthcare facilities in the region. However, Asia Pacific is expected to emerge as the fastest-growing market due to growing patient population, increasing awareness, and improving access to healthcare. Regional analysis Asia Pacific region is projected to witness the highest growth during the forecast period owing to the large patient base, healthcare infrastructure development, and rising disposable incomes. Countries like China, India, and Japan are major contributors to the regional market. Availability of generic drugs and medical devices at affordable prices also makes respiratory therapy accessible to a wider population. Key players Key players operating in the respiratory inhalers market include Unilever, Procter & Gamble, Reckitt Benckiser, Henkel AG & Co. KGaA, Church & Dwight Co. Inc., Wipro Enterprises Limited, Colgate-Palmolive Company, C.Johnson & Son Inc., Godrej Consumer Products, Kao Corporation, L'Oreal S.A., The Clorox Company, Seventh Generation, Inc., Natura &Co, Weleda Group, Patanjali Ayurved Limited, Hain Celestial, EO Products, Indus Valley, Prairie Rose. For more insights, read- https://www.pressreleasebulletin.com/respiratory-inhalers-market-trends-size-and-share-analysis/
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
February 2024
Categories
All
|